Offering will be conducted by Jefferies, Oppenheimer, Wedbush PacGrow
By Devika Patel
Knoxville, Tenn., Aug. 18 – Eiger BioPharmaceuticals, Inc. said it priced a $20 million public sale of stock with a $3 million greenshoe. The deal was announced Wednesday.
The company will sell 1.25 million common shares at $16.00 apiece. The price per share is a 6.92% discount to the Aug. 17 closing share price of $17.19.
Jefferies LLC is the bookrunner.
Settlement is expected Aug. 23.
Proceeds will be used for clinical development, working capital and other general corporate purposes.
The biopharmaceutical company is based in Palo Alto, Calif.
| Issuer: | Eiger BioPharmaceuticals, Inc.
|
| Issue: | Common shares
|
| Amount: | $20 million
|
| Greenshoe: | $3 million, or 187,500 shares
|
| Shares: | 1.25 million
|
| Price: | $16.00
|
| Warrants: | No
|
| Bookrunners: | Jefferies LLC
|
| Co-managers: | Oppenheimer & Co. Inc. and Wedbush PacGrow
|
| Announcement date: | Aug. 17
|
| Pricing date: | Aug. 18
|
| Settlement date: | Aug. 23
|
| Stock symbol: | Nasdaq: EIGR
|
| Stock price: | $17.19 at close Aug. 17
|
| Market capitalization: | $110.19 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
